Development of non-peptide ACE inhibitors as novel and potent cardiovascular therapeutics: An in silico modelling approach-Reference-Cited by-同舟云学术

Development of non-peptide ACE inhibitors as novel and potent cardiovascular therapeutics: An in silico modelling approach

Published:2018-07-03 Issue:7 Volume:29 Page:503-515
ISSN:1062-936X
Container-title:SAR and QSAR in Environmental Research
language:en
Short-container-title:SAR and QSAR in Environmental Research

Author:

Stoičkov V.¹,Šarić S.¹,Golubović M.²,Zlatanović D.³,Krtinić D.⁴,Dinić L.⁵,Mladenović B.⁶,Sokolović D.⁷,Veselinović A.M.⁸

Affiliation:

1. Institute for Cardiovascular Rehabilitation, Faculty of Medicine, University of Nis, Niska Banja, Serbia

2. Center for Anesthesiology and Reanimatology, Clinical Center Niš, Niš, Serbia

3. Clinic for Physical Medicine and Rehabilitation, Clinical Center Niš, Niš, Serbia

4. Department for Pharmacology and Toxicology, Faculty of Medicine, University of Niš, Serbia

5. Department of Urology, Clinical Center Niš, Niš, Serbia

6. Clinic of Gastroenterology and Hepatology, Clinical Center Niš, Niš, Serbia

7. Department of Biochemistry, Faculty of Medicine, University of Niš, Niš, Serbia

8. Department of Chemistry, Faculty of Medicine, University of Niš, Niš, Serbia

Funder

Ministry of Education and Science, the Republic of Serbia,

Publisher

Informa UK Limited

Subject

Drug Discovery,Molecular Medicine,General Medicine,Bioengineering

Link

https://www.tandfonline.com/doi/pdf/10.1080/1062936X.2018.1485737

Reference47 articles.

1. Local renin–angiotensin systems: the unanswered questions

2. The angiotensin converting enzyme (ACE)

3. E.K. Jackson, Renin and angiotensin, in Goodman and Gilman’s the Pharmacologic Basis of Therapeutics, 10th ed. J.G. Hardman, L.E. Limberd and A.G. Gilman, eds., McGrawHill, New York, 2001, pp. 809–829.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico study to recognize novel angiotensin-converting-enzyme-I inhibitors by 2D-QSAR and constraint-based molecular simulations;Journal of Biomolecular Structure and Dynamics;2023-05-02

2. In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition;Chemical Papers;2022-04-03

3. Protein-protein interaction networks and protein-ligand docking: Contemporary insights and future perspectives;Acta Facultatis Medicae Naissensis;2021

4. The Application of the Combination of Monte Carlo Optimization Method based QSAR Modeling and Molecular Docking in Drug Design and Development;Mini-Reviews in Medicinal Chemistry;2020-09-01

5. Use of Graph Based Descriptors for Determination of Structural Features Causing Modulation of Fructose-1,6-Bisphosphatase;Drug Research;2020-04-03